Scott Dunseth Myers Dynavax Technologies Corp (DVAX) insider trading activity

Scott Dunseth Myers is Director of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 35,004 shares of DVAX, which is worth approximately $340,238. The most recent transaction as insider was on Aug 22, 2025, when has been sold 3,800 shares (Common Stock) at a price of $10.82 per share, resulting in proceeds of $41,116. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35K

12.18% 3M change

37.56% 12M change

Total Value Held $340,238

Scott Dunseth Myers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 22 2025	BUY Open market or private purchase	$41,116 $10.82 p/Share	3,800 Added 9.79%	35,004 Common Stock
Jun 11 2025	BUY Grant, award, or other acquisition	-	5,758 Added 15.58%	31,204 Common Stock
May 23 2024	BUY Grant, award, or other acquisition	-	5,357 Added 17.39%	25,446 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	5,357 Added 21.05%	20,089 Common Stock

Also insider at

AMAG

AMAG PHARMACEUTICALS, INC.

President & CEO

SELB

SELECTA BIOSCIENCES INC Healthcare

Director

HARP

Harpoon Therapeutics, Inc. Healthcare

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Chief Executive Officer

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

Director

SDM